Masschelein E, Van Thienen R, Wang X, Van Schepdael A, Thomis M, Hespel P. Dietary nitrate improves muscle but not cerebral oxygenation status during exercise in hypoxia. J Appl Physiol 113: 736-745, 2012. First published July 5, 2012 doi:10.1152/japplphysiol.01253.2011.-Exercise tolerance is impaired in hypoxia, and it has recently been shown that dietary nitrate supplementation can reduce the oxygen (O 2) cost of muscle contractions. Therefore, we investigated the effect of dietary nitrate supplementation on arterial, muscle, and cerebral oxygenation status, symptoms of acute mountain sickness (AMS), and exercise tolerance at simulated 5,000 m altitude. Fifteen young, healthy volunteers participated in three experimental sessions according to a crossover study design. From 6 days prior to each session, subjects received either beetroot (BR) juice delivering 0.07 mmol nitrate/kg body wt/day or a control drink (CON). One session was in normoxia with CON (NOR CON); the two other sessions were in hypoxia (11% O 2), with either CON (HYPCON) or BR (HYPBR). Subjects first cycled for 20 min at 45% of peak O 2 consumption (VO2peak; EX45%) and thereafter, performed a maximal incremental exercise test (EX max). Whole-body VO 2, arterial O2 saturation (%SpO2) via pulsoximetry, and tissue oxygenation index of both muscle (TOI M) and cerebral (TOIC) tissue by near-infrared spectroscopy were measured. Hypoxia per se substantially reduced VO 2peak, %SpO2, TOIM, and TOIC (NORCON vs. HYP CON, P Ͻ 0.05). Compared with HYPCON, VO2 at rest and during EX 45% was lower in HYPBR (P Ͻ 0.05), whereas %SpO2 was higher (P Ͻ 0.05). TOI M was ϳ4-5% higher in HYPBR than in HYPCON both at rest and during EX 45% and EXmax (P Ͻ 0.05). TOIC as well as the incidence of AMS symptoms were similar between HYP CON and HYPBR at any time. Hypoxia reduced time to exhaustion in EXmax by 36% (P Ͻ 0.05), but this ergolytic effect was partly negated by BR (ϩ5%, P Ͻ 0.05). Short-term dietary nitrate supplementation improves arterial and muscle oxygenation status but not cerebral oxygenation status during exercise in severe hypoxia. This is associated with improved exercise tolerance against the background of a similar incidence of AMS.
NITRIC OXIDE (NO) IS IMPLICATED in a multiplicity of physiological processes in the human body. Amongst others, this includes vascular control, regulation of muscle contractility, mitochondrial respiration, glucose and calcium homeostasis, and hypoxic vasodilation (14, 15, 23, 39, 47) . NO is endogenously produced by the action of the NO synthase enzyme (NOS) on circulating L-arginine. Alternatively, NO can also be produced from dietary nitrate. Nitrate is a natural ingredient in vegetables and is particularly abundant in leafy greens and beetroots (27) . A fraction of the nitrate ingested is reduced to nitrite by facultative anaerobic bacteria in the saliva and further converted to NO in the acid environment of the stomach (7) . Another fraction is absorbed and may eventually be reduced to NO or to other bioactive nitrogen oxides occurring in blood and tissues (38, 40) .
Interestingly, recent data have provided substantial evidence to indicate that dietary nitrate supplementation in young, healthy volunteers, either in the form of pure sodium nitrate (35, 36) or beetroot (BR) juice (2, 3, 33, 50) , reduces the oxygen (O 2 ) cost of a given intensity of muscle contractions. This translates into higher fraction of oxygenated hemoglobin in muscle (3) , as well as lower rate of whole-body O 2 uptake (VO 2 ) in endurance exercise (2, 3, 33, 35, 36, 50) . The exact physiological mechanisms underlying this "ergogenic" action are only partly understood. However, the observation that L-arginine supplementation, which also may increase NO production but via another route other than nitrate intake, in one study (4) yielded similar ergogenic effects as nitrate intake also supports the assumption that NO is probably the key molecule involved. NO may impact on mitochondrial function via different mechanisms (15, 34) , but also, nitrite has the potential to regulate tissue protein expression and activity directly (11) . Accordingly, a recent study has shown that nitrate administration in healthy volunteers upregulates mitochondrial oxidative phosphorylation efficiency, which probably is at least partly explained by reduced proton leakage across the inner mitochondrial membrane due to downregulation of the ATP/ADP translocase protein. Furthermore, it has also been shown that dietary nitrate supplementation reduces the ATP cost of muscle contractions (2) , which might be linked to a reduced ATP expenditure on maintenance of sarcoplasmic calcium homeostasis (47) . Furthermore, dietary nitrate supplementation also improved high-intensity exercise tolerance, which could be due to enhanced oxidative energy turnover in conjunction with better muscle perfusion due to NO-induced vasodilation during the transition from rest to exercise (14, 23) .
Recent observations also indicate that NO is an important signaling molecule in adaptation to altitude/hypoxia (37) . For instance, altitude residents (ϳTibetans) exhale higher concentrations of NO (6) and have many-fold higher plasma nitrite levels than lowlanders (20) . Furthermore, when lowlanders are exposed to acute hypoxia, the fraction of NO in the expired air decreases (10, 19) , which may be a maladaptive response to hypoxia. In addition, a number of studies have demonstrated that lower exhaled NO levels are associated with a higher incidence of altitude illnesses (16, 18) . A recent study also showed that dietary nitrate reduces muscle metabolic perturbation during exercise in hypoxia (51) . Given the evidence for a beneficial role of NO in hypoxia, it is reasonable to hypothesize that dietary nitrate supplementation could be more potent to enhance exercise performance in hypoxia than in normoxia. An additional argument to support such hypothesis is the fact that NO formation via the L-arginine NOS pathway is inhibited in hypoxic conditions (40) . In such condition, the nitratenitrite-NO pathway probably could serve as a back-up system to maintain sufficient NO levels when O 2 supply is limited.
Against this background, the aim of the present study was to investigate the effect of short-term dietary nitrate supplementation in the form of BR juice on muscle oxygenation status and exercise capacity at high altitude (5,000 m, 11% O 2 ). Because exercise performance at high altitude is often limited even more by acute mountain sickness (AMS) than by muscular deficits per se, we also evaluated the effect of nitrate administration on cerebral oxygenation status and symptoms of AMS. In this regard, we postulated that the reduced O 2 cost of submaximal exercise at high altitude could facilitate maintenance of higher arterial partial pressure of O 2 (pO 2 ) and thereby inhibit the development of AMS.
MATERIALS AND METHODS
Subjects. Fifteen healthy, physically active males [age: 21.1 Ϯ 1.0 yr; body wt: 72.3 Ϯ 2.5 kg; peak VO2 (VO2peak): 61.7 Ϯ 2.1 ml·kg Ϫ1 ·min Ϫ1 ] volunteered to participate in the study, which was approved by the KU Leuven Biomedical Ethics Committee and was in accordance with The Declaration of Helsinki. Subjects gave their written, informed consent after they were fully informed of all experimental procedures and risks associated with the experiments. None of the subjects were tobacco smokers, used dietary supplements, or were exposed to an altitude higher than 1,500 m within 6 mo prior to the study. All subjects were asked to continue their normal sports and other physical activities throughout the study, and they were instructed to restrain from heavy exercise and alcohol for 24 h prior to the experimental sessions. Furthermore, the subjects received a list of nitrate-rich foods to be avoided during the entire study period so as to reduce the amount of involuntary dietary nitrate intake. On the evening before the experiments, the subjects received a standardized dinner [1,000 kcal, carbohydrates 60 percent total energy content (60E%)-fat 27E%-protein 13E%], and the next morning, they consumed a standardized breakfast (700 kcal, carbohydrates 85E%-fat 9E%-protein 6E%), ϳ3 h before the start of the exercise tests, from which time, the use of caffeine-containing nutrients was also prohibited. All tests were performed in the Research Center for Exercise and Health, KU Leuven.
Study protocol. The subjects participated in three experimental exercise sessions in a normobaric hypoxic facility (SportingEdge, Sherfield on Loddon, UK), according to a single blind, randomized crossover study design, and with a 2-wk washout period between the experimental sessions. Prior to each experimental session, the subjects underwent a 6-day dietary supplementation with either BR juice containing 0.07 mmol nitrate/kg body wt/day or an equivalent volume (ϳ500 ml) of apple-black currant juice containing Ͻ5 mol nitrate/kg body wt/day, which served as a control drink (CON). Energy (kcal) content in the form of carbohydrates, fats, and proteins was rather similar between BR and CON. One CON session was performed in normoxia (NORCON; 20.93% ambient O2); the two other sessions were done in severe hypoxia (11% ambient O2, corresponding to ϳ5,000 m altitude)-one session with CON (HYPCON) and the other with BR (HYPBR). The subjects were not aware of the experimental hypotheses and were disinformed on the true composition of the juices. Subjects were instructed to distribute the intake over five equal doses (ϳ100 ml) throughout the day. However, on the day of the experiments, they received the full dose (ϳ500 ml) between 1 and 2 h before the start of the experimental session. During the experimental sessions, the O 2 content in the hypoxic facility was automatically controlled at the pre-set level (20.93% or 11%), and ambient air temperature and relative humidity were maintained at 20°C and 50%, respectively. Two weeks before the start of the study, all subjects performed a familiarization session in the hypoxic facility, set at normoxia, to become familiar with all experimental procedures. At this occasion, a maximal incremental exercise test (EX max) was also performed on a cycle ergometer (Avantronic Cyclus II, Leipzig, Germany) to determine VO 2peak and peak workload, as well as to fix the bike position to be reproduced in the next experimental sessions.
Experimental sessions. For each experimental session, the subjects reported to the laboratory in the morning between 8 and 9 AM. Upon arrival, they rested for 1 h in a comfortable chair, where after resting, blood pressure was measured with a cuff placed on the upper right arm using an electronic sphygmomanometer (Omron M6, Omron Healthcare, Kyoto, Japan). Blood pressure was measured four times at 1-min intervals, and a mean value was calculated using only the last three values measured. Basal pulmonary gas-exchange parameters were then measured during a 5-min period using an open circuit ergospirometry device (Cortex MetaLyzer II, Leipzig, Germany). Finally, a capillary blood sample was collected from the ear lobe for determination of blood lactate, and a blood sample (10 ml) was taken from an arm vein into lithium-heparin tubes for later analysis of plasma nitrate and nitrite. Following these baseline measurements, a cycling exercise protocol (Avantronic Cyclus II) was started. Subjects successively performed a 20-min submaximal constant-load cycling bout at a workload corresponding to 45% of their previously determined VO 2peak (EX45%) and a EXmax test to volitional exhaustion (50 W ϩ 20 W/min), with a 15-min rest interval in between. From the start to the end of the experimental session, heart rate (HR) was measured continuously (Polar, Kempele, Finland), and arterial O2 saturation (%SpO2) was monitored using a pulsoximeter (Nellcor N-600-x, Oxismart, Mallinckrodt, St. Louis, MO) with a sensor placed on the forehead, ϳ2 cm above the right eyebrow. Local oxygenation status in the right m. vastus lateralis and left prefrontal cortex was measured continuously by means of near-infrared spectroscopy (NIRS; NIRO-200, Hamamatsu, Japan; see below for further details). During all exercise tests, pulmonary gas-exchange parameters were measured continuously, and capillary blood samples for lactate assay were collected each 5 min in EX45% and 2 min after the point of exhaustion in EXmax. A 15-point Borg scale (6 -20) was also used to measure ratings of perceived exertion (RPE) immediately after EX45% and EXmax. Following EXmax, the subjects recovered for 30 min in a comfortable chair, after which AMS, symptoms were assessed using the Lake Louise Questionnaire. Presence and severity of symptoms inherent to AMS-like headache, gastrointestinal symptoms, fatigue, and dizziness were evaluated. Each symptom was graded on a scale ranging from zero (absent) to three (most severe). According to the Lake Louise AMS score guidelines, AMS is present when subjects suffer from headache and at least one other symptom, with a total score of three or more (45) .
NIRS. NIRS has become a popular method to measure tissue oxygenation status noninvasively (8) . The principles, limitations, and reliability of NIRS measurements have been described extensively elsewhere (22) . We used the NIRO-200 NIRS instrument (Hamamatsu) for the purpose of this study. One pair of NIRS probes, consisting of one light emitter and one light detector, was attached on the belly of the right m. vastus lateralis in parallel with the long axis of the muscle. The other pair of NIRS probes was attached on the left prefrontal cortex, ϳ2 cm above the left eyebrow as laterally as possible. The probes were fitted in a dark-colored plastic spacer with a fixed interoptode distance of 4 cm and attached to the skin using doublesided adhesive tape. Elastic, noncompressive bandages were used to keep the probes in place. Probe placement was made in an upright standing position before the experimental session started. Before positioning of the probes, the skin was shaved to exclude interaction of hair as a chromophore. The contour lines of the two probes were drawn on the skin with a permanent marker to allow identical repositioning of the probes during each subsequent session. NIRO-200 applies three different wavelengths of near-infrared light and provides real-time information on the dynamic balance between O 2 supply and VO2. The so-called "tissue oxygenation index" (TOI), as determined by spatially resolved spectroscopy, is a valid parameter (8, 42) Blood and plasma analysis. Capillary blood samples from the ear lobe were analyzed immediately for blood lactate concentration using an automated lactate analyzer (Lactate Pro, Arkray, Japan). Venous blood samples were centrifuged immediately (4,000 rpm for 10 min at 4°C), and plasma was separated to be stored at Ϫ80°C for later analysis of nitrate and nitrite. The determination of nitrate and nitrite was carried out by capillary zone electrophoresis (CZE) on HP 3D CE equipment (Agilent, Waldbronn, Germany), as described in detail elsewhere (54) . Briefly, field-amplified sample stacking was used to achieve submicromolar detection by dilution of the plasma sample with deionized water. In CZE, the separation of nitrate and nitrite was achieved within 10 min without adding an electro-osmotic flow modifier. The optimal condition was achieved with 50 mM phosphate buffer at pH 9.3 as a background electrolyte. The separation voltage was 20 kV (negative potential), and UV detection was performed at 214 nm. The temperature of the cassette was kept at 40°C. After thawing at room temperature, 150 l plasma sample was deproteinized by spiking with 5 l 1 M NaOH to pH 10 and then centrifuged at 14,100 g for 10 min in a MiniSpin Plus microcentrifuge (Eppendorf, Hamburg, Germany). Then, the ninefold-diluted plasma samples (100 l supernatant with 800 l water) were injected hydrodynamically for 40 s into a 60-cm ϫ 75-m internal diameter uncoated fused-silica capillary. The capillary was flushed between runs with 0.1 M NaOH (2 min), distilled water (2 min), and running buffer (2 min). Thiocyanate was used as internal standard at a concentration of 10 M. The linearity curves were obtained with the standard addition method, and the estimated limits of detection were 0.07 and 0.05 M in ninefold-diluted plasma sample vs. 0.63 and 0.45 M in original plasma for nitrate and nitrite, respectively. The intra-and interday precision for both analytes was Ͻ2.6%, and the recovery ranged between 92% and 113%. Measured values are consistent with literature data (24) .
Data analysis. Before statistical analysis and to facilitate interpretation of the data, mean values for HR, gas-exchange parameters, %SpO2, and the NIRS values were calculated for: 1) the last 10 min of the rest period, 2) the last 10 min of EX45%, and 3) the final 30 s of EXmax. These values represent the status during rest, submaximal exercise, and maximal exercise, respectively. Furthermore, energy expenditure during the last 10 min of EX45% was calculated from VO2 and carbon dioxide production (VCO2) using the formula of Brouwer (9) : energy expenditure (J/s) ϭ [(3.869 ϫ VO2) ϩ (1.195 ϫ VCO2)] ϫ (4.186/60) ϫ 1,000; and net mechanical efficiency (NE) was calculated: NE (%) ϭ work rate (W)/[energy expenditure (J/s) Ϫ energy expenditure at rest (J/s)] ϫ 100.
Statistics. Separate analyses were run to evaluate the earlier stated hypotheses: 1) the effects of hypoxia per se (NOR CON vs. HYPCON) and 2) to compare the effects of BR vs. CON in hypoxia (HYPCON vs. HYPBR). Two-tailed paired t-tests were used for HR, exercise capacity, resting and peak blood lactate, gas-exchange parameters, NE, blood pressure, plasma nitrate and nitrite, RPE, and AMS to compare NOR CON vs. HYPCON on the one hand and HYPCON vs. HYPBR on the other hand. Exercise-induced changes in NIRS variables, %SpO2, and blood lactate during EX45% were evaluated by a two-way repeated measures ANOVA to determine the main effects of conditions (Fc; NORCON vs. HYPCON, HYPCON vs. HYPBR) as well as to assess the condition ϫ time interaction (Fi). As a post hoc comparison, a Bonferroni t-test was used when appropriate. A Bonferroni t-test was also used to evaluate specific preplanned comparisons. A probability level P Ͻ 0.05 was considered statistically significant. All data are expressed as means Ϯ SE.
RESULTS
Plasma nitrate and nitrite. Plasma nitrate and nitrite were similar between NOR CON and HYP CON (Table 1) . Compared with HYP CON , in HYP BR , plasma nitrate was increased ϳ3.5-fold (P Ͻ 0.05), whereas plasma nitrite was increased by ϳ40% (P Ͻ 0.05).
HR, blood lactate, and exercise capacity. Compared with NOR CON , in HYP CON , HR at rest and during EX 45% was increased substantially, whereas peak HR (HRpeak) was reduced (Table 2) . HR was similar between HYP CON and HYP BR at all times. Compared with NOR CON (1.3 Ϯ 0.1 mmol/l), blood lactate at rest was higher in both HYP CON (1.9 Ϯ 0.1 mmol/l, P Ͻ 0.05) and HYP BR (1.7 Ϯ 0.1 mmol/l, P Ͻ 0.05). Blood lactate in NOR CON did not increase during EX 45% (Fig. 1) . However, in HYP CON , blood lactate increased progressively to ϳ5-6 mmol/l. Throughout EX 45%, blood lactate was lower in HYP BR than in HYP CON (F c ϭ 4.8, P Ͻ 0.05), yet the difference was only significant from 10 to 15 min (P Ͻ 0.05). During EX max , compared with NOR CON (888 Ϯ 37 s), time to exhaustion in HYP CON (568 Ϯ 23 s) was decreased by 36% (P Ͻ 0.05). In HYP BR (597 Ϯ 22 s), time to exhaustion was slightly higher (ϩ5%, P Ͻ 0.05; Fig. 2 ) than in HYP CON . In fact, in 13 out of 15 subjects, time to exhaustion was longer in HYP BR than in HYP CON (Fig. 2) . Blood lactate during EX max peaked at 10.6 Ϯ 0.3 mmol/l in NOR CON vs. 9.1 Ϯ 0.5 mmol/l in HYP CON (P Ͻ 0.05). Peak lactate was similar between HYP CON and HYP BR (9.6 Ϯ 0.5 mmol/l). Pulmonary gas exchange and NE. Compared with NOR CON , in HYP CON at rest and during EX 45% , ventilation (VE) (P Ͻ 0.05), VCO 2 (P Ͻ 0.05), and respiratory exchange ratio (RER; P Ͻ 0.05) were increased, whereas VO 2 was unchanged ( Table  2) . VO 2 was lower in HYP BR than in HYP CON , both at rest (Ϫ8%, P Ͻ 0.05) and during EX 45% (Ϫ4%, P Ͻ 0.05). VCO 2 at rest was similar between HYP CON and HYP BR , but during EX 45% , VCO 2 was slightly lower (Ϫ5%, P Ͻ 0.05) in the latter. RER and VE were similar between HYP CON and HYP BR . During EX max and compared with NOR CON , VO 2 peak (Ϫ35%, P Ͻ 0.05) peak VCO 2 (VCO 2 peak; Ϫ33%, P Ͻ 0.05), and peak VE (VEpeak; Ϫ7%, P Ͻ 0.05) were reduced in HYP CON , yet peak RER (RERpeak) was similar. VO 2 peak, VCO 2 peak, RERpeak, and VEpeak were similar between HYP CON and HYP BR . Furthermore, no difference was found in NE between NOR CON (18.6 Ϯ 0.5%) and HYP CON (19.0 Ϯ 0.5%). However, NE tended to be higher in HYP BR (19.9 Ϯ 0.5%, P ϭ 0.07) than in HYP CON .
%SpO 2 . Figure 3A shows the typical time course of %SpO 2 changes throughout an experimental session. In normoxia (NOR CON ), %SpO 2 was mostly stable, although slightly dropping at EX max . Conversely, in hypoxia (HYP CON and HYP BR ), %SpO 2 started from a substantially lower baseline level and dropped further during exercise. From these curves, mean values (see MATERIALS AND METHODS for details) were calculated for rest, EX 45% , and EX max (Fig. 3B) . Compared with NOR CON , %SpO 2 in HYP CON was lower at rest (Ϫ22%, P Ͻ 0.05) and during both EX 45% (Ϫ32%, P Ͻ 0.05) and EX max (Ϫ27%, P Ͻ 0.05). Compared with HYP CON , %SpO 2 was slightly increased in HYP BR both at rest (ϩ3.5%, P Ͻ 0.05) and during EX 45% (ϩ2.7%, P Ͻ 0.05) but not during EX max .
Muscle oxygenation status. In normoxia (NOR CON ), TOI decreased during EX 45% and dropped further during EX max . In hypoxia (HYP CON and HYP BR ), compared with NOR CON , TOI started from a lower baseline level, and in addition, the exercise-induced deoxygenation during EX 45% , but not during EX max , was markedly greater (Fig. 4A) . From these curves, mean values (see MATERIALS AND METHODS for details) were calculated for rest, EX 45% , and EX max (Fig. 4B) . Compared with NOR CON , in HYP CON , TOI was lower during rest (Ϫ11%, P Ͻ 0.05), EX 45% (Ϫ27%, P Ͻ 0.05), and EX max (Ϫ18%, P Ͻ 0.05). Compared with HYP CON , muscle oxygenation status was improved in HYP BR (F c ϭ 14.9, P Ͻ 0.05). Thus TOIs in Values are means Ϯ SE (n ϭ 15) for minute ventilation (VE), O2 uptake (VO2), carbon dioxide output (VCO2), respiratory exchange ratio (RER), and heart rate (HR) during a constant-load exercise bout at 45% of peak VO2 (VO2peak; EX45%) and at peak workload during an incremental exercise test HYP BR at rest (ϩ4%, P Ͻ 0.05), during EX 45% (ϩ4%, P Ͻ 0.05), as well as during EX max (ϩ5%, P Ͻ 0.05) were higher than in HYP CON Cerebral oxygenation status. The typical time course of cerebral TOI in the prefrontal cortex is given in Fig. 5A and Table 4 . In normoxia (NOR CON ), TOI was constant during EX 45% yet decreased slightly at EX max . Similar to muscle TOI, the exercise-induced deoxygenation in the prefrontal cortex was also greater in hypoxia (HYP CON and HYP BR ) than in normoxia (NOR CON ). Again, from these curves, mean values (see MATERIALS AND METHODS for details) were calculated for rest, EX 45% , and EX max (Fig. 5B) . Compared with NOR CON , TOI was lower in HYP CON at rest (Ϫ18%, P Ͻ 0.05), during EX 45% (Ϫ28%, P Ͻ 0.05), and during EX max (Ϫ27%, P Ͻ 0.05). However, there were no differences between HYP CON and HYP BR at any time. Furthermore, compared with NOR CON , the RPE, AMS, and blood pressure. In EX 45% , the Borg scores were higher in HYP CON (13.6 Ϯ 0.7) and HYP BR (13.3 Ϯ 0.5) than in NOR CON (10.1 Ϯ 0.4, P Ͻ 0.05). Conversely, at EX max , Borg scoring was identical among the three conditions (NOR CON : 18.6 Ϯ 0.3; HYP CON : 18.3 Ϯ 0.3; HYP BR : 18.5 Ϯ 0.3). AMS scores were higher in HYP CON (2.5 Ϯ 0.6; range 0 -8) than in NOR CON (0.8 Ϯ 0.2; range 0 -2, P Ͻ 0.05), but there was no significant difference between HYP CON and HYP BR (2.5 Ϯ 0.5; range 0 -6). Still, it is worthwhile to mention that six out of 10 subjects in HYP CON vs. only four in HYP BR were diagnosed positive for AMS ( 2 ϭ 5.0, P ϭ 0.99). Systolic blood pressure was similar between NOR CON (126 Ϯ 2 Torr) and HYP CON (129 Ϯ 3 Torr). However, in HYP BR , systolic pressure was reduced slightly (121 Ϯ 2 Torr, P Ͻ 0.05). Diastolic blood pressure, on average, was 69 Ϯ 1 Torr and was independent of the experimental conditions.
DISCUSSION
Nowadays, many individuals are regularly exposed to exercise in hypoxia, for example, during skiing or hiking at altitude or in mountaineering. Also, some endurance sports involve high-intensity exercise in hypoxia, such as mountain stages in cycling (up to ϳ2,800 m altitude in Tour de France) or mountain running events (i.e., Pikes Peak marathon to ϳ4,300 m in Colorado). It is well known that the drop in arterial pO 2 occurring at altitude impairs exercise tolerance. This ergolytic effect is primarily due to inhibition of oxidative energy production in active muscles, but at higher altitudes, the impact of AMS also comes into prominence. Therefore, any intervention that could improve whole-body O 2 efficiency may stimulate exercise tolerance in hypoxia even more than in normoxia. Against this background, we investigated the effect of dietary nitrate supplementation in the form of BR on muscle and cerebral oxygenation status during submaximal and maximal exercise at simulated high altitude. Subjects were acutely exposed to an exercise protocol involving submaximal and maximal exercise in 11% ambient O 2 . This elicited the expected physiological responses, such as decreased arterial pO 2 and %SpO 2 , along with exaggerated pulmonary VE, decreased muscle and cerebral oxygenation status, elevated lactate production during submaximal exercise, as well as development of AMS symptoms. Compared with normoxia, maximal exercise capacity in hypoxia was also markedly reduced. We hypothesized that supplementary nitrate intake, by reducing the O 2 cost of muscle contractions, could 1) improve muscle oxygenation status for a given exercise intensity, 2) prevent AMS symptoms by suppressing the exercise-induced drop in arterial pO 2 , and 3) via both of these mechanisms, improve exercise capacity. The data clearly demonstrate that nitrate administration beneficially impacted on muscle oxygenation status during both submaximal and maximal exercise in hypoxia. Exercise capacity was concomitantly enhanced. However, neither cerebral oxygenation status nor AMS symptoms were significantly affected by the nitrate supplementation.
Recent studies have shown unanimously that dietary nitrate supplementation can reduce the rate of VO 2 for a given workload during submaximal exercise (2, 3, 33, 35, 36, 50) . In the present study, subjects performed a 20-min constant-load exercise bout at a workload of ϳ45% of sea-level VO 2 peak (EX 45% ), corresponding with ϳ70% of the VO 2 peak measured at simulated 5,000 m altitude. As expected, hypoxia per se did not alter whole-body VO 2 during this submaximal exercise. However, BR ingestion suppressed VO 2 by ϳ4%, which probably largely reflects a reduced rate of VO 2 by active muscles. Thus TOI in m. vastus lateralis was higher in HYP BR than in HYP CON (Fig. 4) , along with a higher fraction of circulating oxygenated hemoglobin (%SpO 2 ; Fig. 3 ) and lower exerciseinduced increase in muscle deoxyhemoglobin content (⌬[HHb]; Table 3 ), indicating a lower rate of muscle O 2 extraction. The lower O 2 cost of EX 45% also translated into a tendency of an improved mechanical efficiency of cycling (ϳ5% increase in net NE, P ϭ 0.07) and lower blood lactate accumulation (Fig. 1) . Taken together, our above findings prove that the effect of acute severe hypoxia to inhibit oxidative energy production in muscles during submaximal exercise is suppressed by dietary nitrate supplementation. This beneficial effect is probably at least partly explained by better coupling of mitochondrial respiration with oxidative phosphorylation (elevated phosphate/O 2 ratio) (34), as well as by a reduced ATP cost for a given rate of muscle contractions (2) .
Contrary to our expectations, the effect of BR on VO 2 was not greater than for similar nitrate supplementation protocols during exercise in normoxia (2, 3, 33, 35, 36, 50) . In this regard, it is important to note that here, we only looked at the effects of an acute bout of severe hypoxia exposure with no prior acclimatization. It has been demonstrated that altitude acclimatization per se can enhance O 2 efficiency during submaximal exercise (41) . Therefore, it is tempting to speculate that long-term altitude acclimatization in conjunction with nitrate supplementation might yield additive effects on O 2 efficiency during exercise.
One would expect a more efficient oxidative energy production due to nitrate intake also to enhance maximal exercise performance at altitude. Therefore, we also investigated the effects of nitrate supplementation on performance in an EX max . Hypoxia per se reduced time to exhaustion by ϳ35%, which is in line with earlier observations at ϳ5,000 m altitude (12, 53) , and BR administration eliminated ϳ5% of this ergolytic effect (Fig. 2) . Conversely, Vanhatalo et al. (51) recently reported BR to increase time to exhaustion by Ͼ15% during an ϳ5-to 10-min constant-load maximal knee-extension test in hypoxia (14.5% ambient O 2 , ϳ3,000 m altitude). However, during exercise with a small muscle group in moderate hypoxia (51), improved muscular O 2 efficiency is likely to translate directly into improved performance, because muscles are overperfused. Thus mitochondrial O 2 use, rather than muscle O 2 delivery, is directly limiting muscle VO 2 . In contrast, during whole-body exercise in severe hypoxia, VO 2 in active muscles is primarily limited by impaired O 2 diffusion due to drop of arterial pO 2 ( Fig. 3) (53) . Furthermore, maximal constant-load tests (51) are often more sensitive than maximal incremental exercise protocols to detect changes in exercise capacity (56) . Moreover, at high altitude, but not at moderate altitude (51), AMS becomes a primary determinant of exercise tolerance. Accordingly, in HYP CON , six out of 15 subjects developed AMS. In these specific subjects, compared with NOR CON , HRpeak dropped by 24 Ϯ 4 beats/min, whereas in the others, it dropped by only 14 Ϯ 3 beats/min (P Ͻ 0.05). This indicates that maximal exercise capacity was limited by AMS symptoms indeed.
Interestingly, the effect of BR to boost maximal exercise capacity in hypoxia (Fig. 2) occurred against the face of unchanged VO 2 peak (Table 2 ). This finding is in line with earlier studies in normoxia, showing improved maximal exercise capacity at constant VO 2 max (2, 3, 50) . This is probably at least partly explained by facilitated oxidative energy turnover throughout the incremental exercise, allowing for better maintenance of high-energy phosphate content and suppression of inorganic phosphate and hydrogen ion accumulation (2, 51) . Such a mechanism is likely to inhibit the development of local muscle fatigue in the final stages of a EX max . Support for greater O 2 efficiency during EX max comes from our observation that TOI in m. vastus lateralis was higher in HYP BR than in HYP CON (Fig. 4) . This was associated with smaller ⌬[HHb] (Table 3 ) and occurred against the face of equal O 2 delivery, as indicated by similar ⌬[THb] (Table 3) , as well as %SpO 2 (Fig.  3) . Accordingly, BR intake in patients afflicted by peripheral arterial disease decreased muscle O 2 extraction in areas of hypoxia, improved tissue oxygenation, as well as enhanced exercise tolerance (31) . Further along this line, BR was also found to stimulate muscle phosphocreatine resynthesis postexercise in hypoxia (51) , which is probably at least partly explained by enhanced blood flow and O 2 delivery to the more hypoxic muscle areas of the muscle and thereby, improved oxidative ATP production (26, 30, 48) .
It has been proposed that increased NO production due to nitrate supplementation may also stimulate exercise performance by promoting muscle blood flow during exercise (25) .
In keeping with earlier studies in normoxia (3, 32, 33) , we found that nitrate intake in hypoxia reduced resting systolic blood pressure, conceivably indicating decreased total peripheral vascular resistance. We did not measure blood pressure during exercise but estimated changes in muscle blood flow during exercise via NIRS. Thus if nitrate intake were successful to increase NO production in muscles during exercise, this clearly did not impact on exercise-induced stimulation of blood flow. It has been previously reported that acute exposure to 10.5%-inspired O 2 content (ϳ5,300 m altitude) slightly increased muscle blood flow during submaximal but not during maximal cycling exercise (12) . In contrast, we found acute exposure to 11% ambient O 2 (NOR CON vs. HYP CON ) not to alter ⌬[THb] during submaximal exercise, indicating unchanged blood flow. In this regard, it is important to note that ⌬[THb] obtained from NIRS is an indirect, semiquantitative measure of blood flow, and therefore, data are normalized relative to the baseline signal (rest). Hence, similar ⌬[THb] does not exclude that absolute rates of blood flow in EX 45% were still higher in HYP CON than in NOR CON due to higher blood flow existing already at rest. However, in the aforementioned study, resting muscle blood flow was not reported (12) . Finally, it has also been suggested by some that NO might contribute to facilitating oxidative energy production during the transition from rest to exercise by stimulating local vasodilation and O 2 delivery to muscle cells (14) . However, the slopes of ⌬[THb] at the onset of either EX 45% or EX max were identical between HYP CON and HYP BR , indicating that such vascular effect was probably unimportant.
Another hypothesis driving the current study was that nitrate administration could enhance exercise capacity at altitude by preventing central mechanisms limiting exercise performance. It is the prevailing opinion that the drop of cerebral O 2 delivery, which also results in increased formation of reactive O 2 species (1), plays an important role in the development of AMS and high-altitude cerebral edema (HACE), which impair exercise tolerance (28, 52) . Therefore, any intervention able to improve cerebral oxygenation status conceivably could stimulate exercise performance at high altitude. Here, we measured cerebral oxygenation status in the prefrontal cortex using NIRS. In keeping with literature data (28, 52) , basal oxygenation status (TOI) in the prefrontal cortex was lower in hypoxia than in normoxia (Fig. 5) 45% and EX max . In addition, BR did not consistently inhibit the development of AMS. This may reflect the fact that physiological responses to acute hypoxia by definition are probably primarily targeted to protect the central nervous system from hypoxic damage (13, 44) , which makes exogenous stimulation of NO synthesis by nitrate ingestion redundant. In addition, autoregulation of cerebral blood flow is only abolished once %SpO 2 drops below 60% (43) . This threshold was not exceeded in the conditions of the present study, either at rest or during exercise (%SpO 2 Ͼ 60%; Fig. 3 ), which concurs with earlier observations (12, 53) . Nonetheless, it would be premature to conclude from the present findings that oral nitrate is ineffective to inhibit the development of AMS. First, it is the prevailing opinion that the drop of arterial O 2 content occurring in hypoxia is the primary trigger of AMS (5) . Interestingly, we here for the first time demonstrate that oral nitrate supplementation can increase the fraction of oxygenated arterial hemoglobin (%SpO 2 ) both at rest and during submaximal exercise. It is well documented that a drop of alveolar pO 2 limits pulmonary O 2 diffusion capacity at high altitude, which results in a drop of %SpO 2 (13, 46) . In the face of impaired pulmonary O 2 diffusion, the rate of peripheral O 2 use becomes an important determinant of circulating arterial O 2 content. Therefore, the effect of nitrate ingestion to improve peripheral O 2 efficiency [ Table 2 and refs. (2, 3, 33, 35, 36, 50) ] should increase %SpO 2 , particularly because oxyhemoglobin saturation in severe hypoxia is operating on the steep segment of the oxyhemoglobin dissociation curve. Second, the hypoxic stimulus imposed to our subjects was moderate (ϳ2 h at ϳ5,000 m), which limited the incidence as well as the severity of AMS symptoms. The potential of nitrate supplementation to prevent AMS by increasing %SpO 2 may become more pertinent during a more severe hypoxic challenge at extreme altitude (Ͼ5,500 m). In fact, the small arterial [O 2 Hb] desaturation induced by short exposure to 11% ambient O 2 would be largely negated by short-term acclimatization (13) . Finally, oxygenation status measured at the site of the prefrontal cortex may not be representative for oxygenation status in other brain areas that play a more prominent role in the pathogenesis of AMS, such as the temporal region (21) .
By analogy with other recent studies, we have used BR juice as a vehicle for nitrate supplementation. However, BR juice contains many substances other than nitrate, including betaine, antioxidants, and polyphenols, which also could affect physiological responses. However, studies with denitrificated BR juice have indicated that the known physiological effects of BR consumption, at least in normoxia, are mainly if not entirely accounted for by its high nitrate content (32, 33) . In keeping with earlier observations, in the conditions of the current study, BR raised plasma nitrate concentration by a factor ϳ3.5, which resulted in a 40% increment in plasma nitrite (Table 1) . This effect was clearly ample to enhance muscular O 2 efficiency during exercise in hypoxia. Still, the rise in plasma nitrate and nitrite was smaller than in other studies using similar nitrate dosages in young, healthy volunteers (2, 3, 32, 33, 35, 36) . This is probably, at least partly, explained by the fact that we administered BR in small aliquots over a 1-h period, whereas others used a bolus (2, 3, 32, 33, 35, 36) , which conceivably resulted in lower peak plasma levels. In addition, blood samples were taken 2 h after the last BR aliquot, which is before peak plasma nitrite levels normally occur (55) . Plasma nitrite concentrations were approximately tenfold higher than in most other recent studies looking at the effects of nitrate supplementation in young, healthy subjects indeed (2, 3, 32, 33, 50, 51) yet were within the range of basal plasma nitrite values reported in literature (24, 29) .
In conclusion, oral nitrate supplementation improves muscle oxygenation status during both submaximal and maximal exercise in severe acute hypoxia. This is associated with enhanced exercise capacity. In the conditions of the present study, nitrate intake did not inhibit a hypoxia-induced drop of cerebral oxygenation or the development of AMS. However, the fraction of oxygenated arterial hemoglobin was increased significantly at rest, as well as during submaximal exercise. It remains to be investigated whether muscle O 2 sparing, due to nitrate intake during prolonged exposure to high altitude, can elevate arterial O 2 content to such a degree that prevention of AMS and HACE becomes an additional mechanism for improvement of exercise tolerance.
